The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $2,580.74 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Doxepin HCL 6 mg tablets, with an ultimate completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,826.21, is a firm fixed-price delivery order for 4,563,169,498 units of the pharmaceutical product Doxepin HCL 6 mg Tablet 30s. The contract has an ultimate completion date of December 26, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,781.44, is for the delivery of Doxepin HCL 3 mg tablets. This is a Firm Fixed Price Delivery Order that does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Doxepin Hydrochloride 3 mg tablets to support the Defense Logistics Agency (DLA) Troop Support Medical program. The firm-fixed-price delivery order, valued at $1,815.47, has an ultimate completion date of December 6, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation mentioned. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,383.69 Firm Fixed Price Delivery Order (Contract #SPE2DB22D1017|SPE2DB24FF7GQ) is for the supply of 4,564,529,766 units of Doxepin HCL 3 mg tablets, with a performance period through May 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is a $1,028.73 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) to provide 4557845128 doxepin HCL 3 mg tablets in 30-count packages. The contract has an ultimate completion date of July 20, 2022 and was awarded on July 19, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award, valued at $4,389.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of Doxepin Hydrochloride 3 mg tablets. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Doxepin HCL 3 MG Tablets in packages of 30. The $1,795.44 contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received numerous federal contracts from DLA to supply pharmaceuticals and medical supplies for military treatment programs and facilities....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,767.93, is for the delivery of Doxepin HCL 3 mg tablets. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on January 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,953.24, is for the delivery of Doxepin HCL 3 mg tablets and has an ultimate completion date of January 3, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026....